MY156432A - Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation - Google Patents

Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation

Info

Publication number
MY156432A
MY156432A MYPI2010004281A MYPI20104281A MY156432A MY 156432 A MY156432 A MY 156432A MY PI2010004281 A MYPI2010004281 A MY PI2010004281A MY PI20104281 A MYPI20104281 A MY PI20104281A MY 156432 A MY156432 A MY 156432A
Authority
MY
Malaysia
Prior art keywords
ebv
reactivation
epstein
synthetic peptide
barr virus
Prior art date
Application number
MYPI2010004281A
Other languages
English (en)
Inventor
Drouet Emmanuel
Original Assignee
Univ Joseph Fourier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Joseph Fourier filed Critical Univ Joseph Fourier
Publication of MY156432A publication Critical patent/MY156432A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/05—Epstein-Barr virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MYPI2010004281A 2008-03-10 2009-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation MY156432A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08290224A EP2101177A1 (en) 2008-03-10 2008-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (EBV) reactivation

Publications (1)

Publication Number Publication Date
MY156432A true MY156432A (en) 2016-02-26

Family

ID=39595705

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2010004281A MY156432A (en) 2008-03-10 2009-03-10 Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation

Country Status (9)

Country Link
US (1) US20110076671A1 (https=)
EP (2) EP2101177A1 (https=)
JP (1) JP5592277B2 (https=)
CN (1) CN102016586B (https=)
AT (1) ATE530913T1 (https=)
CA (1) CA2718245C (https=)
ES (1) ES2375095T3 (https=)
MY (1) MY156432A (https=)
WO (1) WO2009112497A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2983482B1 (fr) * 2011-12-05 2017-10-20 Univ Joseph Fourier Utilisation d'au moins un biomarqueur pour le pronostic ou le diagnostic in vitro d'episodes lymphoproliferatifs associes au virus d'epstein-barr (ebv)
WO2014025254A1 (en) 2012-08-10 2014-02-13 Stichting Vu-Vumc Ebv markers and systemic lupus erythematosus
CN109679975B (zh) * 2019-01-23 2020-12-08 济宁医学院 一种改造bzlf1和改造lmp1的融合基因及其应用
CN113061165B (zh) * 2020-01-02 2026-04-21 厦门大学 EB病毒BNLF2b基因编码多肽及其检测用途
CN111826412A (zh) * 2020-06-02 2020-10-27 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种高通量检测eb病毒感染效率/抗体阻断eb病毒感染效率的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE428724T1 (de) * 1992-09-15 2009-05-15 Ortho Diagnostic Systems Inc Immunreaktive peptide des epstein-barrvirus
FR2728904B1 (fr) * 1995-01-04 1997-03-14 Pasteur Institut Reactif peptidique permettant de detecter une infection primaire a virus d'epstein-barr par recherche des anticorps correspondants, et procede d'utilisation de ce reactif
PT747481E (pt) * 1995-06-06 2002-05-31 Organon Teknika Bv Peptidos do virus de epstein-barr e anticorpos contra estes peptidos
JPH11511853A (ja) * 1996-03-29 1999-10-12 オルソ ダイアグノスティック システムズ インク エプスタイン・バーウイルス関連疾患の診断法
FR2791142B1 (fr) * 1999-03-17 2001-06-22 Univ Grenoble 1 Utilisation de la brefeldine a pour augmenter l'effet de presentation d'antigenes exogenes par les cpa
JP5492418B2 (ja) * 2005-11-18 2014-05-14 ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション ウイルス関連疾患を予防するためのウイルス遺伝子産物およびワクチン接種の方法

Also Published As

Publication number Publication date
CN102016586B (zh) 2015-01-21
WO2009112497A1 (en) 2009-09-17
EP2269069B1 (en) 2011-10-26
CN102016586A (zh) 2011-04-13
JP2011513759A (ja) 2011-04-28
CA2718245A1 (en) 2009-09-17
EP2101177A1 (en) 2009-09-16
US20110076671A1 (en) 2011-03-31
ATE530913T1 (de) 2011-11-15
JP5592277B2 (ja) 2014-09-17
ES2375095T3 (es) 2012-02-24
EP2269069A1 (en) 2011-01-05
CA2718245C (en) 2017-04-18

Similar Documents

Publication Publication Date Title
MX2009005788A (es) Peptidos truncados de hormona paratiroidea con una conformacion ciclica.
MX2010003380A (es) Proteinas de union a antigeno de factor de crecimiento tipo factor de crecimiento epidermico de union a heparina.
PH12013500277A1 (en) ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
EA201290557A1 (ru) Пептидный аналог оксинтомодулина
MX2009013137A (es) Metodos para seleccionar polipeptidos resistentes a la proteasa.
IL222879A0 (en) Peptides for treatment and diagnosis of autoimmune disease
MY156432A (en) Use of synthetic peptide derived from zebra protein for the in vitro diagnosis of the epstein-barr virus (ebv) reactivation
ATE548049T1 (de) Verwendung von ides proteinase (von s. pyogenes) zur behandlung von autoimmunkrankheiten und transplantatabstossung
FI3256579T3 (fi) Kysteiiniproteaasi
EP2615105A4 (en) CELL PERMEABLE PEPTIDE, BIOACTIVE PEPTIDE CONJUGATE, AND USE THEREOF FROM HUMAN CELLS
JO3330B1 (ar) الأجسام المضادة cgrp
PH12012501308A1 (en) Binding members for human cytomegalovirus
SG179095A1 (en) Novel assay for the detection of amyloid beta peptides
IN2012DN03178A (https=)
IL202598A0 (en) High sensitivity immunoassays and kits for the determination of peptides and proteins of biological interest
NZ599590A (en) Factor involved in latent infection with herpesvirus, and use thereof
NZ609501A (en) Antibodies to notum pectinacetylesterase
WO2006086799A3 (en) Prion-specific peptide reagents
EP1870015A4 (en) ENDOSCOPE FIXATION, ENDOSCOPE TREATMENT INSTRUMENT AND ENDOSCOPIC SYSTEM
CY1114618T1 (el) Βιολογικα δραστικα πεπτιδια που περιεχουν καρβοξυτελικη αργινινη
MX2009001937A (es) Biomarcadores para el progreso de la enfermedad de alzheimer.
MY155340A (en) Use of cathepsin c
SG170804A1 (en) Pseudomonas aeruginosa outer membrane protein pa0427
EP2552462A4 (en) CCN3 THERAPEUTIC PEPTIDES AND THEIR ANALOGS
WO2008060634A3 (en) Human complement c3 derivatives with cobra venom factor-like function